MicroTransponder Overview
- Year Founded
-
2007

- Status
-
Private
- Employees
-
119

- Latest Deal Type
-
Series F
- Latest Deal Amount
-
$65M
- Investors
-
16
MicroTransponder General Information
Description
Developer of an implantable neurostimulation device designed to aid stroke recovery, tinnitus management, and other neurological disorders. The company's device incorporates paired vagus nerve stimulation and wireless technology to deliver targeted electrical impulses, enhancing neuroplasticity, restoring motor function in post-stroke patients, and reducing tinnitus perception, enabling healthcare practitioners to improve patient rehabilitation outcomes.
Contact Information
Website
www.microtransponder.comCorporate Office
- 2802 Flintrock Trace
- Suite 226
- Austin, TX 78738
- United States
Corporate Office
- 2802 Flintrock Trace
- Suite 226
- Austin, TX 78738
- United States
MicroTransponder Timeline
MicroTransponder Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
14. Later Stage VC (Series F) | 12-Mar-2025 | $65M | Completed | Generating Revenue | ||
13. Mezzanine | 31-Dec-2023 | Completed | Generating Revenue | |||
12. Accelerator/Incubator | 01-Jun-2023 | Completed | Generating Revenue | |||
11. Later Stage VC (Series E) | 21-Sep-2022 | Completed | Generating Revenue | |||
10. Debt - PPP | 08-Apr-2020 | Completed | Generating Revenue | |||
9. Later Stage VC (Series D) | 17-Nov-2017 | Completed | Generating Revenue | |||
8. Grant | 01-Jan-2016 | Completed | Generating Revenue | |||
7. Later Stage VC (Series C) | 10-Dec-2015 | Completed | Generating Revenue | |||
6. Later Stage VC (Series B) | 01-May-2013 | $4.32M | $16.7M | Completed | Generating Revenue | |
5. Grant | 01-Jan-2013 | $5.24M | $12.3M | Completed | Generating Revenue |
MicroTransponder Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series F | ||||||||
Series E-2 | ||||||||
Series E-1 | ||||||||
Series D | ||||||||
Series C | ||||||||
Series B | 4,229,000 | $0.010000 | $3.74 | $3.74 | 1x | $3.74 | 4.95% | |
Series A | 1,401,000 | $0.010000 | $1.91 | $1.91 | 1x | $1.91 | 1.64% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
MicroTransponder Comparisons
Industry
Financing
Details
MicroTransponder Competitors (43)
One of MicroTransponder’s 43 competitors is Mainstay Medical, a Venture Capital-Backed company based in San Diego, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Mainstay Medical | Venture Capital-Backed | San Diego, CA | ||||
Neuronetics | Formerly VC-backed | Malvern, PA | ||||
Aleva Neurotherapeutics | Private Equity-Backed | Lausanne, Switzerland | ||||
Advanced Bionics | Formerly VC-backed | Valencia, CA | ||||
Fisher Wallace Labs | Venture Capital-Backed | New York, NY |
MicroTransponder Patents
MicroTransponder Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11167130-B2 | Manipulation member for nerve cuff | Active | 26-Jun-2018 | ||
US-20190388680-A1 | Manipulation member for nerve cuff | Active | 26-Jun-2018 | ||
EP-2776121-B1 | Methods, systems, and devices for treating tinnitus with vns pairing | Active | 10-Nov-2011 | ||
EP-2776121-A1 | Methods, systems, and devices for treating tinnitus with vns pairing | Active | 10-Nov-2011 | ||
EP-4032583-A1 | Systems, and devices for treating tinnitus with vns pairing | Pending | 13-Oct-2011 | A61N1/36067 |
MicroTransponder Signals
MicroTransponder Investors (16)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Gilde Healthcare | Venture Capital | Minority | ||
Longitude Capital | Venture Capital | Minority | ||
MedTech Innovator | Accelerator/Incubator | Minority | ||
Action Potential Venture Capital | Corporate Venture Capital | Minority | ||
Angel (individual) | Minority |
MicroTransponder FAQs
-
When was MicroTransponder founded?
MicroTransponder was founded in 2007.
-
Where is MicroTransponder headquartered?
MicroTransponder is headquartered in Austin, TX.
-
What is the size of MicroTransponder?
MicroTransponder has 119 total employees.
-
What industry is MicroTransponder in?
MicroTransponder’s primary industry is Therapeutic Devices.
-
Is MicroTransponder a private or public company?
MicroTransponder is a Private company.
-
What is the current valuation of MicroTransponder?
The current valuation of MicroTransponder is
. -
What is MicroTransponder’s current revenue?
The current revenue for MicroTransponder is
. -
How much funding has MicroTransponder raised over time?
MicroTransponder has raised $207M.
-
Who are MicroTransponder’s investors?
Gilde Healthcare, Longitude Capital, MedTech Innovator, Action Potential Venture Capital, and are 5 of 16 investors who have invested in MicroTransponder.
-
Who are MicroTransponder’s competitors?
Mainstay Medical, Neuronetics, Aleva Neurotherapeutics, Advanced Bionics, and Fisher Wallace Labs are some of the 43 competitors of MicroTransponder.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »